Bubs Australia Ltd shares are down almost 30% in less than two weeks

The Bubs Australia Ltd (ASX:BUB) share price has continued to sink lower. Are more declines on the way?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Unfortunately for its shareholders the Bubs Australia Ltd (ASX: BUB) share price has taken another sharp tumble during trade today.

At the time of writing the baby food and goat milk infant formula company's shares are down over 9% to 78 cents.

This means Bubs' shares have lost almost 30% of their value since peaking at $1.10 earlier this month.

What happened?

Bubs' shares have come under significant pressure this week after one of its major shareholders offloaded over 6.8 million shares on market.

By doing so, Next Step Global Limited reduced its stake in the company to 12.4% from 14.6% previously.

Some investors appear to be interpreting this as a sign that its shares are overvalued and have headed to the exits in order to take profit off the table or limit their losses.

Are Bubs' shares overvalued?

Based on its current sales Bubs' shares are vastly overvalued. However, it has positioned itself extremely well to potentially grow its top line significantly in the future.

Through supply agreements with both major online e-commerce platforms and mother and baby stores in China, I believe Bubs has an outside chance of growing into its valuation in the future.

However, I have found its sales growth thus far to be reasonably underwhelming. For all the hard work the company has done in positioning the company, if Chinese consumers don't take to the product as they have with a2 Milk Company Ltd (Australia) (ASX: A2M) and Bellamy's Australia Ltd (ASX: BAL), then these supply agreements count for very little.

In light of this, I don't believe the risk/reward on offer at the moment is compelling enough to make an investment and suggest investors wait to see how its sales develop in the coming quarters.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »